Revealing the Mechanisms of Byu dMar 25 in the Treatment of Alzheimer’s Disease through Network Pharmacology, Molecular Docking, and In Vivo Experiment
Open Access
- 13 June 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (28) , 25066-25080
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative disease, severely reducing the cognitive level and life quality of patients. Byu dMar 25 (BM25) has been proved to have a therapeutic effect on AD. However, the pharmacological mechanism is still unclear. Therefore, this study aims to reveal the potential mechanism of BM25 affecting AD from the perspective of network pharmacology and experimental validation. The potential active ingredients of BM25 were obtained from the TCMSP database and literature. Possible targets were predicted using SwissTargetPrediction tools. AD-related genes were identified by using GeneCards, OMIM, DisGeNET, and Drugbank databases. The candidate genes were obtained by extraction of the intersection network. Additionally, the "drug-target-disease" network was constructed by Cytoscape 3.7.2 for visualization. The PPI network was constructed by the STRING database, and the core network modules were filtered by Cytoscape 3.7.2. Enrichment analysis of GO and KEGG was carried out in the Metascape platform. Ledock software was used to dock the critical components with the core target. Furthermore, protein levels were evaluated by immunohistochemistry. In this study, 112 active components, 1112 disease candidate genes, 3084 GO functions, and 277 KEGG pathways were obtained. Molecular docking showed that the effective components of BM25 in treating AD were β-asarone and hydroxysafflor yellow A. The most important targets were APP, PIK3R1, and PIK3CA. Enrichment analysis indicated that the Golgi genetic regulation, peroxidase activity regulation, phosphatidylinositol 3-kinase complex IA, 5-hydroxytryptamine receptor complexes, cancer pathways, and neuroactive ligand-receptor interactions played vital roles against AD. The rat experiment verified that BM25 affected PI3K-Akt pathway activation in AD. This study reveals the mechanism of BM25 in treating AD with network pharmacology, which provides a foundation for further study on the molecular mechanism of AD treatment.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2021A1515011580, 2021B1515140012, 2023A1515010083)
- Guangdong Medical Research Foundation (A2020096, B2021330)
- Research and Development Fund of Dongguan Peoples Hospital (k202005)
- Dongguan Science and Technology of Social Development Program (20211800905342)
- Administration of Traditional Chinese Medicine of Guangdong Province (20211216)
- Scientific Research Fund of Guangdong Medical University (GDMUZ2020009)
- Guangdong medical university students Innovation and entrepreneurship training program (GDMU2021003, GDMU2021049, GDMU2022031, GDMU2022047, GDMU2022063, GDMU2022077, GDMU2022078)
- Guangdong medical university students Innovation experiment program (2020ZYDS005, 2020ZZDS002, 2021ZCDS003, 2021ZZDS006, 2022FCDS003, 2022FYDB009, 2022ZYDS003)
- Provincial and national college students innovation and entrepreneurship training program (202110571010, 202210571008, S202110571078, S202210571075)
- Guangdong Medical University-Southern Medical University twinning research team project (4SG23033G)
- Cai Limin National Traditional Chinese Medicine Inheritance Studio
This publication has 46 references indexed in Scilit:
- Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic miceEuropean Journal of Pharmacology, 2014
- TCMSP: a database of systems pharmacology for drug discovery from herbal medicinesJournal of Cheminformatics, 2014
- Oxidative stress in Alzheimer’s diseaseNeuroscience Bulletin, 2014
- 神经炎症抑制剂用于阿尔茨海默症的药物研发Chinese Science Bulletin, 2014
- Identification and analysis of absorbed components and their metabolites in rat plasma and tissues after oral administration of ‘Ershiwuwei Shanhu’ pill extracts by UPLC-DAD/Q-TOF-MSJournal of Ethnopharmacology, 2013
- PI3-kinase/Akt/mTOR signaling: Impaired on/off switches in aging, cognitive decline and Alzheimer's diseaseExperimental Gerontology, 2013
- ZINC: A Free Tool to Discover Chemistry for BiologyJournal of Chemical Information and Modeling, 2012
- Alzheimer Mechanisms and Therapeutic StrategiesCell, 2012
- The emerging mechanisms of isoform-specific PI3K signallingNature Reviews Molecular Cell Biology, 2010
- Akt-mediated Cardiomyocyte Survival Pathways Are Compromised by Gαq-induced Phosphoinositide 4,5-Bisphosphate DepletionJournal of Biological Chemistry, 2003